Don’t Let Bristol-Myers’s Megamerger Fool You
A deal may not always be the best prescription. (Photographer: George Frey/Bloomberg)

Don’t Let Bristol-Myers’s Megamerger Fool You

(Bloomberg Opinion) -- Just when the megamerger megacycle looked like it was coming to an end, bam! A $74 billion deal gets announced three days into the new year. (It’s precisely why you should ne...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.